ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update

RTTNews | 806 dni temu
ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) initiates adjusted earnings and net revenue guidance for the full-year 2023.

For fiscal 2023, the company now projects adjusted earnings in a range of $2.09 to $2.59 per share on net revenues between $360 million and $385 million, with purified cortrophin gel revenue at $80 million to $90 million.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.62 per share on revenues of $352.49 million for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

read more
Asian Shares Mixed In Cautious Trade

Asian Shares Mixed In Cautious Trade

Asian stocks ended mixed on Friday despite a retreat in U.S. Treasury yields and comments from a Federal Reserve official that the U.S. central bank might lower interest rates in 2025 if tariff issues are resolved.
RTTNews | 1g 44 minut temu
UK Retail Sales Growth Tops Expectations On Warm Weather

UK Retail Sales Growth Tops Expectations On Warm Weather

UK retail sales rebounded more than expected in April as good weather boosted food store sales, official data showed on Friday. A monthly survey today showed that British consumer confidence strengthened in May on hopes of easing trade tensions and the interest rate reduction by the Bank of England. Retail sales grew 1.2 percent on a monthly basis in April, following a revised 0.1 percent rise
RTTNews | 2g 15 minut temu